RANOLAZINE AT THE END OF TRASTUZUMAB THERAPY PREVENTS LEFT VENTRICULAR DYSFUNCTION: IN VITRO AND IN VIVO STUDY

被引：0
|
作者：
Maurea, Nicola [1 ]
Coppola, Carmela [1 ]
Piscopo, Giovanna [1 ]
Rea, Domenica [1 ]
Riccio, Gennaro [1 ]
Condorelli, Gerolama [1 ]
Arra, Claudio [1 ]
de Lorenzo, Claudia [1 ]
机构：
[1] IRCCS, Ist Nazl Studio & Cura, Tumori Fdn Giovanni Pascale, Naples, Italy
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(16)31355-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1103-084
引用
收藏
页码：1354 / 1354
页数：1
相关论文
共 50 条
  • [1] Ranolazine at the end of Trastuzumab therapy prevents left ventricular dysfunction
    Maurea, N.
    Coppola, C.
    Piscopo, G.
    Galletta, F.
    Maurea, C.
    Rea, D.
    Esposito, E.
    Riccio, G.
    De Lorenzo, C.
    Arra, C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 254 - 254
  • [2] Long-term therapy with ranolazine prevents progressive left ventricular dysfunction and remodeling in dogs with chronic heart failure
    Sabbah, HN
    Imai, M
    Morita, H
    Stanley, WC
    Blackburn, B
    CIRCULATION, 2004, 110 (17) : 679 - 680
  • [3] Left Ventricular Dysfunction With Trastuzumab Therapy: Is Primary Prevention the Best Option?
    Thavendiranathan, Paaladinesh
    Amir, Eitan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (08) : 820 - U193
  • [4] Cardioprotection induced by ranolazine after trastuzumab treatment: the reduction of cardiotoxicity in vitro and in vivo study
    Maurea, N.
    Coppola, C.
    Piscopo, G.
    Galletta, F.
    Maurea, C.
    Rea, D.
    Riccio, G.
    Maiolino, P.
    Arra, C.
    De Lorenzo, C.
    EUROPEAN HEART JOURNAL, 2015, 36 : 148 - 148
  • [5] Ranolazine prevents ischemia-induced ST segment changes and left ventricular mechanical dysfunction in rabbits
    Wang, Wei-Qun
    Robertson, Chelsea
    Ivey, Paige
    Dhalla, Arvinder K.
    Belardinelli, Luiz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A184 - A185
  • [6] Irreversible left atrium dilatation preceding left ventricular dysfunction during trastuzumab therapy
    Dolci, Giulia
    Bergamini, Corinna
    Fiorio, Elena
    Ribichini, Flavio
    MINERVA CARDIOANGIOLOGICA, 2018, 66 (02): : 223 - 224
  • [7] Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction
    Yu, Anthony F.
    Yadav, Nandini U.
    Eaton, Anne A.
    Lung, Betty Y.
    Thaler, Howard T.
    Liu, Jennifer E.
    Hudis, Clifford A.
    Dang, Chau T.
    Steingart, Richard M.
    ONCOLOGIST, 2015, 20 (10): : 1105 - 1110
  • [8] Ranolazine Prevents Heart Failure with Preserved Ejection Fraction; Diastolic Dysfunction and Left Ventricular Hypertrophy in a Hypertensive Murine Model
    Valadri, R.
    Gadesam, R.
    Onwuanyi, A.
    Fan, M. T.
    Bloom, H.
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (08) : S13 - S13
  • [9] Early Identification of Left Ventricular Dysfunction Induced by Trastuzumab
    Tocchetti, Carlo G.
    Coppola, Carmela
    Arra, Claudio
    Maurea, Nicola
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (25) : 2698 - 2699
  • [10] Ranolazine reduces symptoms and arrhytmia in patients with ischaemic left ventricular dysfunction
    Marazzi, G.
    Campolongo, G.
    Massaro, R.
    Pasceri, V.
    Rosano, G. M. C. Giuseppe M. C.
    Volterrani, M.
    Pelliccia, F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 341 - 341
12345